ArticleActa pharmaceutica Sinica. B2024

Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy.

Zaigang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.